SNStephan Niemann

Stephan Niemann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephan Niemann has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Hiroaki Kanki

    Laboratory for Behavioral Genetics, RIKEN Brain Science Institute, Wako, Saitama 351‐0198, Japan

    1 shared publication
  • Jeremy M. Shefner

    Department of Neurology, Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, USA

    1 shared publication
  • Keizo Takao

    Department of Behavioral Physiology, Graduate School of Innovative Life Science, University of Toyama, Toyama, Japan

    1 shared publication
  • Masahiko Watanabe

    Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060‐8638, Japan

    1 shared publication
  • Masahiro Fukaya

    Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060‐8638, Japan

    1 shared publication
  • Meri N. Hynynen

    Cecil B. Day Laboratory for Neuromuscular Research

    1 shared publication

Latest Publications

  • Analysis of a genetic defect in the TATA box of the SOD1 gene in a patient with familial amyotrophic lateral sclerosis

    by Stephan Niemann, Wendy J. Broom, Robert H. Brown Jr.

    We report a patient with autosomal-dominant amyotrophic lateral sclerosis (ALS) and a sequence variation in the SOD1 promoter region, located in the conserved TATA box motif (TATAAA→TGTAAA). Functional promoter studies of this variant in an in vitro system showed moderate reduction in transcriptional activity of SOD1. This variant was present in only two of 301 individuals with sporadic amyotrophic lateral sclerosis, was not detected in 396 matched controls, and was recently reported in dbSNP (rs7277748). Our data suggest that this TATA box defect is not a disease-causing mutation or susceptibility factor for ALS but rather a rare polymorphism with a potential effect on SOD1 gene expression. Muscle Nerve, 2007


  • Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypes

    by Stephan Niemann, Hiroaki Kanki, Yasuyuki Fukui, Keizo Takao, Masahiro Fukaya, Meri N. Hynynen, Michael J. Churchill, Jeremy M. Shefner, Roderick T. Bronson, Robert H. Brown, et al.

    NR3B is a modulatory subunit of the NMDA receptor, abundantly expressed in both cranial and spinal somatic motoneurons and at lower levels in other regions of the brain as well. Recently, we found the human NR3B gene (GRIN3B) to be highly genetically heterogeneous, and that ∼ 10% of the normal European‐American population lacks NR3B due to homozygous occurrence of a null allele in the gene. Therefore, it is especially important to understand the phenotypic consequences of the genetic loss of NR3B in both humans and animal models. We here provide results of behavioral analysis of mice genetically lacking NR3B, which is an ideal animal model due to homogeneity in genetic and environmental background. The NR3B–/– mice are viable and fertile. Consistent with the expression of NR3B in somatic motoneurons, the NR3B–/– mice showed a moderate but significant impairment in motor learning or coordination, and decreased activity in their home cages. Remarkably, the NR3B–/– mice showed a highly increased social interaction with their familiar cage mates in their home cage but moderately increased anxiety‐like behaviour and decreased social interaction in a novel environment, consistent with the inhibitory role of NR3B on the functions of NMDA receptors. This work is the first reporting of the functional significance of NR3B in vivo and may give insight into the contribution of genetic variability of NR3B in the phenotypic heterogeneity among human population.